IL112738A - 5-[3-aryl-prop-2-ynyl]-5-(arylsulfonyl)- thiazolidine-2, 4-diones and 5-(3-aryl-prop-2-ynyl)-5- (arylsulfanyl) thiazolidine-2, 4-diones derivatives thereof and pharmaceutical compositions containing them - Google Patents
5-[3-aryl-prop-2-ynyl]-5-(arylsulfonyl)- thiazolidine-2, 4-diones and 5-(3-aryl-prop-2-ynyl)-5- (arylsulfanyl) thiazolidine-2, 4-diones derivatives thereof and pharmaceutical compositions containing themInfo
- Publication number
- IL112738A IL112738A IL11273895A IL11273895A IL112738A IL 112738 A IL112738 A IL 112738A IL 11273895 A IL11273895 A IL 11273895A IL 11273895 A IL11273895 A IL 11273895A IL 112738 A IL112738 A IL 112738A
- Authority
- IL
- Israel
- Prior art keywords
- substituted phenyl
- ynyl
- thiazolidine
- prop
- aryl
- Prior art date
Links
- 150000001473 2,4-thiazolidinediones Chemical class 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000005163 aryl sulfanyl group Chemical group 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 11
- -1 2-pyridinyl Chemical group 0.000 abstract 8
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 abstract 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 abstract 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 229920001774 Perfluoroether Chemical group 0.000 abstract 1
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 230000003345 hyperglycaemic effect Effects 0.000 abstract 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 abstract 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/70—Sulfur atoms
- C07D277/74—Sulfur atoms substituted by carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20798094A | 1994-03-08 | 1994-03-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL112738A0 IL112738A0 (en) | 1995-05-26 |
| IL112738A true IL112738A (en) | 1999-09-22 |
Family
ID=22772754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11273895A IL112738A (en) | 1994-03-08 | 1995-02-22 | 5-[3-aryl-prop-2-ynyl]-5-(arylsulfonyl)- thiazolidine-2, 4-diones and 5-(3-aryl-prop-2-ynyl)-5- (arylsulfanyl) thiazolidine-2, 4-diones derivatives thereof and pharmaceutical compositions containing them |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US5605918A (es) |
| EP (1) | EP0749430B1 (es) |
| JP (1) | JPH09509963A (es) |
| KR (1) | KR100342761B1 (es) |
| AT (1) | ATE183743T1 (es) |
| AU (1) | AU679626B2 (es) |
| BR (1) | BR9507014A (es) |
| CA (1) | CA2184739A1 (es) |
| CZ (1) | CZ284592B6 (es) |
| DE (1) | DE69511683T2 (es) |
| DK (1) | DK0749430T3 (es) |
| ES (1) | ES2135711T4 (es) |
| FI (1) | FI963467A0 (es) |
| GR (1) | GR3031496T3 (es) |
| HU (1) | HUT76482A (es) |
| IL (1) | IL112738A (es) |
| NZ (1) | NZ282143A (es) |
| RU (1) | RU2126395C1 (es) |
| SG (1) | SG52318A1 (es) |
| SK (1) | SK280914B6 (es) |
| TW (1) | TW300222B (es) |
| UA (1) | UA45333C2 (es) |
| WO (1) | WO1995024400A1 (es) |
| ZA (1) | ZA951847B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998040488A1 (en) * | 1997-03-12 | 1998-09-17 | Smithkline Beecham Corporation | Anti-alphabeta3 humanized monoclonal antibodies |
| WO2003018011A1 (en) * | 2001-08-24 | 2003-03-06 | Wyeth Holdings Corporation | 5-(substituted)-5-(substitutedsulfonyl or sulfanyl)thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase |
| US6605628B1 (en) | 2001-08-24 | 2003-08-12 | Wyeth Holdings Corporation | Method of using 5-(arysulfonyl)-, 5-(arylsulfanyl)-and 5-(arylsulfanyl)thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase |
| WO2003018554A1 (en) * | 2001-08-24 | 2003-03-06 | Wyeth Holdings Corporation | 3-substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase |
| WO2003018135A1 (en) * | 2001-08-24 | 2003-03-06 | Wyeth Holdings Corporation | Method of using 5-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase |
| AU2010278777B2 (en) | 2009-07-31 | 2015-05-07 | Global Alliance For Tb Drug Development | Nitroimidazooxazines and their uses in anti-tubercular therapy |
| US9198913B2 (en) | 2009-07-31 | 2015-12-01 | Global Alliance For Tb Drug Development | Nitroimidazooxazines and their uses in anti-tubercular therapy |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58118577A (ja) * | 1982-01-07 | 1983-07-14 | Takeda Chem Ind Ltd | チアゾリジン誘導体 |
| AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| US4738972A (en) * | 1985-05-21 | 1988-04-19 | Pfizer Inc. | Hypoglycemic thiazolidinediones |
| US4743611A (en) * | 1986-07-02 | 1988-05-10 | American Home Products Corp. | Naphthalenylsulfonylimidazolidinediones and their thioxo analogs useful as aldose reductase inhibitors |
| US5068342A (en) * | 1989-10-27 | 1991-11-26 | American Home Products Corporation | 5-[(1- and 2-naphthalenyl)thio and sulfonyl]-2,4-thiazolidinediones and derivatives thereof |
| US4997948A (en) * | 1989-10-27 | 1991-03-05 | American Home Products | 5-[(1- and 2-naphthalenyl) sulfonyl]-2,4-thiazolidinediones and derivatives thereof |
| TW420669B (en) * | 1994-03-28 | 2001-02-01 | Nissan Chemical Ind Ltd | Pyridine type thiazolidines |
-
1995
- 1995-02-08 DK DK95911696T patent/DK0749430T3/da active
- 1995-02-08 HU HU9602442A patent/HUT76482A/hu unknown
- 1995-02-08 UA UA96103817A patent/UA45333C2/uk unknown
- 1995-02-08 AU AU19168/95A patent/AU679626B2/en not_active Ceased
- 1995-02-08 CA CA002184739A patent/CA2184739A1/en not_active Abandoned
- 1995-02-08 NZ NZ282143A patent/NZ282143A/en unknown
- 1995-02-08 EP EP95911696A patent/EP0749430B1/en not_active Expired - Lifetime
- 1995-02-08 SG SG1996002718A patent/SG52318A1/en unknown
- 1995-02-08 WO PCT/US1995/001782 patent/WO1995024400A1/en active IP Right Grant
- 1995-02-08 BR BR9507014A patent/BR9507014A/pt not_active IP Right Cessation
- 1995-02-08 KR KR1019960705020A patent/KR100342761B1/ko not_active IP Right Cessation
- 1995-02-08 JP JP7523463A patent/JPH09509963A/ja not_active Withdrawn
- 1995-02-08 CZ CZ962594A patent/CZ284592B6/cs not_active IP Right Cessation
- 1995-02-08 RU RU96120159A patent/RU2126395C1/ru active
- 1995-02-08 DE DE69511683T patent/DE69511683T2/de not_active Expired - Fee Related
- 1995-02-08 ES ES95911696T patent/ES2135711T4/es not_active Expired - Lifetime
- 1995-02-08 AT AT95911696T patent/ATE183743T1/de not_active IP Right Cessation
- 1995-02-08 SK SK1133-96A patent/SK280914B6/sk unknown
- 1995-02-22 TW TW084101622A patent/TW300222B/zh active
- 1995-02-22 IL IL11273895A patent/IL112738A/xx not_active IP Right Cessation
- 1995-03-06 ZA ZA951847A patent/ZA951847B/xx unknown
- 1995-05-24 US US08/448,851 patent/US5605918A/en not_active Expired - Lifetime
- 1995-05-24 US US08/449,063 patent/US5574051A/en not_active Expired - Lifetime
-
1996
- 1996-09-04 FI FI963467A patent/FI963467A0/fi unknown
-
1999
- 1999-10-11 GR GR990402589T patent/GR3031496T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI963467A (fi) | 1996-09-04 |
| KR970701704A (ko) | 1997-04-12 |
| SG52318A1 (en) | 1998-09-28 |
| CA2184739A1 (en) | 1995-09-14 |
| GR3031496T3 (en) | 2000-01-31 |
| CZ259496A3 (en) | 1997-07-16 |
| AU679626B2 (en) | 1997-07-03 |
| TW300222B (es) | 1997-03-11 |
| FI963467A0 (fi) | 1996-09-04 |
| RU2126395C1 (ru) | 1999-02-20 |
| ATE183743T1 (de) | 1999-09-15 |
| EP0749430B1 (en) | 1999-08-25 |
| IL112738A0 (en) | 1995-05-26 |
| ES2135711T3 (es) | 1999-11-01 |
| KR100342761B1 (ko) | 2002-12-06 |
| CZ284592B6 (cs) | 1999-01-13 |
| US5605918A (en) | 1997-02-25 |
| MX9603865A (es) | 1997-07-31 |
| HUT76482A (en) | 1997-09-29 |
| DE69511683T2 (de) | 2000-03-02 |
| EP0749430A1 (en) | 1996-12-27 |
| SK113396A3 (en) | 1997-03-05 |
| UA45333C2 (uk) | 2002-04-15 |
| US5574051A (en) | 1996-11-12 |
| ES2135711T4 (es) | 2000-01-01 |
| ZA951847B (en) | 1996-09-06 |
| BR9507014A (pt) | 1997-09-09 |
| HU9602442D0 (en) | 1996-11-28 |
| AU1916895A (en) | 1995-09-25 |
| JPH09509963A (ja) | 1997-10-07 |
| WO1995024400A1 (en) | 1995-09-14 |
| NZ282143A (en) | 1997-12-19 |
| SK280914B6 (sk) | 2000-09-12 |
| DK0749430T3 (da) | 2000-02-07 |
| DE69511683D1 (de) | 1999-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU743411B2 (en) | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | |
| KR100204433B1 (ko) | 4-아미노피리미딘 유도체 | |
| CN103153968B (zh) | 三唑衍生物及含有其的具有镇痛作用的药物组合物 | |
| KR890005095A (ko) | 신규 화합물들 | |
| EP2383263B1 (en) | Novel thiazolidinedione derivative and use thereof | |
| KR890014533A (ko) | 혈당 감소제 티아졸리딘디온 유도체 | |
| CA2486399A1 (en) | Calcium receptor modulating agents | |
| PE20081532A1 (es) | Compuestos novedosos | |
| KR960017648A (ko) | 옥사졸리딘디온 유도체, 그의 제법 및 용도 | |
| KR950703539A (ko) | 당뇨병 합병증 치료용 치환된 피리미딘(substituted pyrimidines for control or diabetic complications) | |
| ATE45736T1 (de) | Benzofuran- und benzothiophen-derivate, ihre verwendung zur hemmung der leukotrien-biosynthese bei saeugetieren und diese derivate enthaltende pharmazeutische zusammensetzungen. | |
| RU2007120519A (ru) | Арилоксизамещенное производное бензимидазола | |
| KR20100092909A (ko) | 잔틴 옥시다제 저해제로서 효과적인 신규 화합물, 그 제조방법 및 그를 함유하는 약제학적 조성물 | |
| RU2007107349A (ru) | Пиперазиновые производные, применение для лечения желудочно-кишечных расстройств | |
| KR940014392A (ko) | 티아졸리딘디온 유도체, 그의 제조방법 및 용도 | |
| RU2367659C2 (ru) | Гетероарильные производные в качестве активаторов рецепторов, активируемых пролифераторами пероксисом (ppar) | |
| IL112738A (en) | 5-[3-aryl-prop-2-ynyl]-5-(arylsulfonyl)- thiazolidine-2, 4-diones and 5-(3-aryl-prop-2-ynyl)-5- (arylsulfanyl) thiazolidine-2, 4-diones derivatives thereof and pharmaceutical compositions containing them | |
| DE3664912D1 (en) | 5-(azolyloxyphenylcarbamoyl)-barbituric acid derivatives as active agents in anthelmics | |
| RU2124011C1 (ru) | Производное (1-гетероазолил-1-гетероциклил)алкана, или его геометрические или оптические изомеры или рацематы, или его фармацевтически приемлемые кислые соли присоединения, или его сольваты, способы его получения, ацилзамещенные соединения, фармацевтическая композиция, обладающая нейрозащитными свойствами | |
| KR880701237A (ko) | 광활성 아졸 살충제 | |
| KR930002314A (ko) | 아릴알킬아민 유도체 | |
| RU96120159A (ru) | Производные тиазолидиндиона в качестве противогипергликемических средств | |
| KR960704853A (ko) | 피리다지논 유도체 또는 그의 염, 그의 제조 방법 및 그를 함유하는 항쇼크제 (Pyridazinone Derivatives or their Salts, Processes for their Production, and Anti-Shock Agents Containing Them) | |
| ATE269862T1 (de) | Substituierte thiazolidinedione und oxazolidinedione mit antidiabetischen, hypolipidämischen und antihypertensiven eigenschaften | |
| KR940005621A (ko) | 벤조[b]티오펜-3-일-피페라진. 이의 제조방법 및 약제로서 이의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |